Overview
Industry
Bank accounts
Registered as a VAT taxpayer on 2014-06-06. Active
No bank accounts reported to the VAT Taxpayer Register.
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Sep 18, 2019 | Bankruptcy notice | |
| Oct 17, 2017 | Bankruptcy notice | |
| Nov 7, 2016 | Bankruptcy notice | |
| Nov 7, 2016 | Bankruptcy notice |
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Trademarks
Access Pharma currently holds no active trademarks with the Polish Patent Office. 20 marks have expired or were not registered. The first mark was filed in 2014.
| Mark | Protected until | |
|---|---|---|
| Nosparin(word) | – | |
| Hydroxinum(word) | – | |
| Smectinex(word) | – | |
| Smectin(word) | – | |
| Smectinum(word) | – |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, the following person or persons are authorised to submit declarations of will on behalf of the company: 1. one member of the management board or a commercial proxy acting independently (if no Vice-President of the Management Board has been appointed in the company), up to the amount of PLN 5,000.00 (five thousand zlotys); 2. two members of the management board, including the President of the Management Board, or a member of the management board and a commercial proxy, or the President of the Management Board and a commercial proxy, acting jointly (if no Vice-President of the Management Board has been appointed in the company), above the amount of PLN 5,000.00 (five thousand zlotys); 3. a member of the management board acting jointly with the Vice-President of the Management Board, or a commercial proxy acting with the Vice-President of the Management Board (if a Vice-President of the Management Board has been appointed in the company); 4. in the case of a one-person management board – one member of the management board independently.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 801 | $10,818.48 | 19.5223% | |
| 1,602 | $21,636.95 | 39.0446% | |
Witold Maleszka (54) | 1,600 | $21,609.94 | 38.9959% |
Others | 100 | $1,350.62 | 2.4372% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - LekS.A. | $119,621,017.71 | hasco-lek.pl | ||
| PolfarmexS.A. | $73,543,379.32 | polfarmex.pl | ||
| Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss BiomedS.A. | $37,103,878.54 | biomed.pl | ||
| Fagronsp. z o.o. | $21,715,187.73 | fagron.pl | ||
| Krakowskie Zakłady Zielarskie Herbapol w KrakowieS.A. | $7,294,338.51 | herbapol.krakow.pl | ||
| Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o. | $1,184,204.34 | labor.com.pl | ||
| F1 PharmaS.A. | $272,113.66 | f1pharma.pl | ||
| BIO Animalisp. z o.o. | $49,176.96 | proanimali.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Zakład Farmaceutyczny Amarasp. j. | $0.00 | amara.pl |
Change history
| Date | Event | |
|---|---|---|
| 2022-07-28 | Name change (Access Pharma Spółka Z Ograniczoną Odpowiedzialnością W Upadłości → Access Pharma) | |
| 2021-11-22 | Address change (Bobrzyńskiego 14, 30-348, Kraków → Ul. Zygmunta Radnickiego 11, 30-498, Kraków) | |
| 2016-11-02 | Name change (Access Pharma → Access Pharma Spółka Z Ograniczoną Odpowiedzialnością W Upadłości) | |
| 2015-05-19 | Share capital change (160,150.00 PLN → 205,150.00 PLN) | |
| 2015-05-19 | PKD change (Removed: 10.83.Z, 10.92.Z, 11.07.Z, 47.74.Z, 47.75.Z, 77.40.Z, 82.20.Z, 82.99.Z) |
FAQ
Last updated: 2026-04-08